Page last updated: 2024-11-03

propentofylline and Neuralgia, Postherpetic

propentofylline has been researched along with Neuralgia, Postherpetic in 2 studies

Neuralgia, Postherpetic: Pain in nerves, frequently involving facial SKIN, resulting from the activation the latent varicella-zoster virus (HERPESVIRUS 3, HUMAN). The two forms of the condition preceding the pain are HERPES ZOSTER OTICUS; and HERPES ZOSTER OPHTHALMICUS. Following the healing of the rashes and blisters, the pain sometimes persists.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Landry, RP1
Jacobs, VL1
Romero-Sandoval, EA1
DeLeo, JA1
Watkins, LR1
Hutchinson, MR1
Johnson, KW1

Reviews

1 review available for propentofylline and Neuralgia, Postherpetic

ArticleYear
Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages.
    Experimental neurology, 2012, Volume: 234, Issue:2

    Topics: Animals; Humans; Macrophages; Microglia; Neuralgia, Postherpetic; Tumor Necrosis Factor-alpha; Xanth

2012

Other Studies

1 other study available for propentofylline and Neuralgia, Postherpetic

ArticleYear
Commentary on Landry et al.: "Propentofylline, a CNS glial modulator, does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages".
    Experimental neurology, 2012, Volume: 234, Issue:2

    Topics: Animals; Humans; Macrophages; Microglia; Neuralgia, Postherpetic; Xanthines

2012